PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Calcific aortic stenosis (CAS) can cause severe adverse cardiac events, but there are currently no effective drugs that can prevent or delay the progression of the disease. Our trial aims to investigate the effect of PCSK9 inhibitors on preventing or delaying the progression of CAS.
Epistemonikos ID: 681ba828d7a1fda8d09be26518991a6df51ad40b
First added on: Dec 02, 2025